EE
ABBV icon

EWG Elevate’s AbbVie ABBV Stock Holding History

EWG Elevate’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$850K Sell
3,672
-147
-4% -$29.9K 0.27% 66
2025
Q2 		$709K Buy
3,819
+241
+7% +$44.8K 0.22% 84
2025
Q1 		$750K Buy
3,578
+5
+0.1% +$972 0.28% 62
2024
Q4 		$635K Sell
3,573
-12
-0.3% -$2.21K 0.19% 89
2024
Q3 		$708K Buy
3,585
+6
+0.2% +$1.12K 0.28% 58
2024
Q2 		$614K Sell
3,579
-50
-1% -$8.28K 0.22% 83
2024
Q1 		$661K Buy
3,629
+56
+2% +$9.65K 0.25% 77
2023
Q4 		$554K Sell
3,573
-24
-0.7% -$3.5K 0.23% 64
2023
Q3 		$536K Buy
+3,597
New +$528K 0.24% 60
2023
Q1 		– Sell
-792
Closed -$128K – 94
2022
Q4 		$128K Buy
+792
New +$121K 0.06% 100

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EWG Elevate's ABBV Position: Q3 2025 in Review

EWG Elevate reduced its AbbVie (ABBV) stake by 3.8% in Q3 2025, selling an estimated $29.9K and leaving 3,672 shares worth $850K. The position accounts for 0.27% of the portfolio, ranked #66.

EWG Elevate first reported a position in ABBV in Q4 2022 and has held it in 10 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • EWG Elevate held 3,672 shares of AbbVie worth $850K as of Q3 2025.
  • EWG Elevate sold 147 AbbVie shares in Q3 2025, an estimated $29.9K.
  • AbbVie made up 0.27% of EWG Elevate's portfolio in Q3 2025, its #66 holding.
  • EWG Elevate first reported a position in AbbVie in Q4 2022 and has held it in 10 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on EWG Elevate's 13F filing for Q3 2025, filed 7 Oct 2025.